Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
暂无分享,去创建一个
D. Sotiriadis | A. Trigoni | A. Patsatsi | M. Kokolios | F. Lamprou | D. Stylianidou | Dimitrios Kalampalikis
[1] C. Sitaru,et al. Role of physical factors in the pathogenesis of bullous pemphigoid: Case report series and a comprehensive review of the published work , 2016, The Journal of dermatology.
[2] D. Zillikens,et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology , 2015, The British journal of dermatology.
[3] D. Zillikens,et al. Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] A. España,et al. Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain , 2014, The British journal of dermatology.
[5] A. Serwin,et al. Incidence and mortality of bullous pemphigoid in north‐east Poland (Podlaskie Province), 1999–2012: a retrospective bicentric cohort study , 2014, International journal of dermatology.
[6] D. Sotiriadis,et al. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score. , 2014, Acta dermato-venereologica.
[7] M. Brites,et al. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients* , 2014, Anais brasileiros de dermatologia.
[8] D. Sotiriadis,et al. Association of Autoantibodies to BP180 with Disease Activity in Greek Patients with Bullous Pemphigoid , 2012, Clinical & developmental immunology.
[9] P. Courville,et al. Incidence and mortality of bullous pemphigoid in France. , 2012, The Journal of investigative dermatology.
[10] H. Shimizu,et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. , 2012, Journal of the American Academy of Dermatology.
[11] C. Chams‐Davatchi,et al. Spectrum of autoimmune bullous diseases in Iran: a 10‐year review , 2012, International journal of dermatology.
[12] M. Hertl,et al. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[13] M. Mokni,et al. Spectrum of autoimmune blistering dermatoses in Tunisia: an 11‐year study and a review of the literature , 2011, International journal of dermatology.
[14] M. Jonkman,et al. The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy , 2011, The British journal of dermatology.
[15] P. Tuchinda,et al. Prevalence and clinical features of Thai patients with bullous pemphigoid. , 2011, Asian Pacific journal of allergy and immunology.
[16] Enno Schmidt,et al. Modern diagnosis of autoimmune blistering skin diseases. , 2010, Autoimmunity reviews.
[17] E. Bröcker,et al. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[18] J. Fairley,et al. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. , 2009, The Journal of allergy and clinical immunology.
[19] R. Hubbard,et al. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study , 2008, BMJ : British Medical Journal.
[20] B. Thiers. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects , 2008 .
[21] C. Sitaru,et al. Immunopathology and molecular diagnosis of autoimmune bullous diseases , 2007, Journal of cellular and molecular medicine.
[22] A. Markopoulos,et al. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: Retrospective study of 129 patients , 2007, International journal of dermatology.
[23] E. Alpsoy,et al. Pemphigus in the Mediterranean region of Turkey: A study of 148 cases , 2006, International journal of dermatology.
[24] Z. Naraghi,et al. Pemphigus: Analysis of 1209 cases , 2005, International journal of dermatology.
[25] A. Nanda,et al. Spectrum of autoimmune bullous diseases in Kuwait , 2004, International journal of dermatology.
[26] C. Scully,et al. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[27] L. Vaillant,et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.
[28] N. Tsankov,et al. Epidemiology of pemphigus in Sofia, Bulgaria. A 16‐year retrospective study (1980–1995) , 2000, International journal of dermatology.
[29] B. Rye,et al. Autoimmune bullous diseases. , 1997, American family physician.